Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Cost of goods sold

Other segment segments

Similar metrics at other companies

REZIProducts and Solutions — Cost of goods sold

$411M+8.2%

INDVReportable Segment — Cost of Sales

$40M-9.1%

FTVAdvanced Healthcare Solutions — Cost of Product and Service Sold

$134.5M+8.4%

LQD

LQDAProduct — Cost of Goods Sold

$11.08M—

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

NOVTMedical Solutions — Cost of Goods Sold

$71.73M+15.6%

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s affordable medicines — cost of goods sold?

Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — cost of goods sold of $232.44M in Q1 2026.

How has Amneal Pharmaceuticals, Inc.'s affordable medicines — cost of goods sold changed year-over-year?

Amneal Pharmaceuticals, Inc.'s affordable medicines — cost of goods sold decreased by 4.2% year-over-year, from $242.63M to $232.44M.

What is the long-term trend for Amneal Pharmaceuticals, Inc.'s affordable medicines — cost of goods sold?

Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s affordable medicines — cost of goods sold has grown at a 5.8% compound annual growth rate (CAGR), from $896.03M to $1.06B.

What does affordable medicines — cost of goods sold mean?

Includes the direct costs attributable to the production of the pharmaceutical products sold within the Affordable Medicines segment, such as raw materials, manufacturing labor, and overhead. Monitoring this metric is essential for evaluating the segment's production efficiency and supply chain cost management.